These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19844931)

  • 1. Cortistatin A is a high-affinity ligand of protein kinases ROCK, CDK8, and CDK11.
    Cee VJ; Chen DY; Lee MR; Nicolaou KC
    Angew Chem Int Ed Engl; 2009; 48(47):8952-7. PubMed ID: 19844931
    [No Abstract]   [Full Text] [Related]  

  • 2. Fragment-based discovery of 6-substituted isoquinolin-1-amine based ROCK-I inhibitors.
    Ray P; Wright J; Adam J; Bennett J; Boucharens S; Black D; Cook A; Brown AR; Epemolu O; Fletcher D; Haunso A; Huggett M; Jones P; Laats S; Lyons A; Mestres J; de Man J; Morphy R; Rankovic Z; Sherborne B; Sherry L; van Straten N; Westwood P; Zaman GZ
    Bioorg Med Chem Lett; 2011 Jan; 21(1):97-101. PubMed ID: 21145740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the mediator subunit cyclin C and its implications for CDK8 function.
    Hoeppner S; Baumli S; Cramer P
    J Mol Biol; 2005 Jul; 350(5):833-42. PubMed ID: 15979093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional kinases: Less is more (or less).
    Boyer TG
    Nat Chem Biol; 2016 Jan; 12(1):4-5. PubMed ID: 26678610
    [No Abstract]   [Full Text] [Related]  

  • 5. The structure of CDK8/CycC implicates specificity in the CDK/cyclin family and reveals interaction with a deep pocket binder.
    Schneider EV; Böttcher J; Blaesse M; Neumann L; Huber R; Maskos K
    J Mol Biol; 2011 Sep; 412(2):251-66. PubMed ID: 21806996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel computational analysis of ligand-induced conformational changes in the ATP binding sites of cyclin dependent kinases.
    Subramanian J; Sharma S; B-Rao C
    J Med Chem; 2006 Sep; 49(18):5434-41. PubMed ID: 16942017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cyclin-dependent kinase 8 module sterically blocks Mediator interactions with RNA polymerase II.
    Elmlund H; Baraznenok V; Lindahl M; Samuelsen CO; Koeck PJ; Holmberg S; Hebert H; Gustafsson CM
    Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15788-93. PubMed ID: 17043218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramolecular cyclopropene-furan [2 + 4] cycloaddition followed by a cyclopropylcarbinyl rearrangement to synthesize the BCD rings of cortistatin A.
    Magnus P; Littich R
    Org Lett; 2009 Sep; 11(17):3938-41. PubMed ID: 19655736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human mediator kinase subunit CDK11 plays a negative role in viral activator VP16-dependent transcriptional regulation.
    Tsutsui T; Umemura H; Tanaka A; Mizuki F; Hirose Y; Ohkuma Y
    Genes Cells; 2008 Aug; 13(8):817-26. PubMed ID: 18651850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Picture story. Reining in CDK.
    Feng H
    Nat Struct Biol; 2001 May; 8(5):391. PubMed ID: 11323710
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV Transcription Is Independent of Mediator Kinases.
    Cary DC; Rheinberger M; Rojc A; Peterlin BM
    AIDS Res Hum Retroviruses; 2019 Aug; 35(8):710-717. PubMed ID: 31044597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity bisubstrate probe for fluorescence anisotropy binding/displacement assays with protein kinases PKA and ROCK.
    Vaasa A; Viil I; Enkvist E; Viht K; Raidaru G; Lavogina D; Uri A
    Anal Biochem; 2009 Feb; 385(1):85-93. PubMed ID: 19017524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of virtual screening with high-throughput screening for the identification of novel Rho-kinase I inhibitors.
    Gong LL; Fang LH; Peng JH; Liu AL; Du GH
    J Biotechnol; 2010 Feb; 145(3):295-303. PubMed ID: 19963024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of the Plasmodium falciparum PK5 ATP-binding site: implications for the design of novel antimalarial agents.
    Keenan SM; Welsh WJ
    J Mol Graph Model; 2004 Jan; 22(3):241-7. PubMed ID: 14629982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cyclin-dependent kinase 11 interacts with 14-3-3 proteins.
    Feng Y; Qi W; Martinez J; Nelson MA
    Biochem Biophys Res Commun; 2005 Jun; 331(4):1503-9. PubMed ID: 15883043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-guided discovery of cyclin-dependent kinase inhibitors.
    Fischmann TO; Hruza A; Duca JS; Ramanathan L; Mayhood T; Windsor WT; Le HV; Guzi TJ; Dwyer MP; Paruch K; Doll RJ; Lees E; Parry D; Seghezzi W; Madison V
    Biopolymers; 2008 May; 89(5):372-9. PubMed ID: 17937404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle. Confirmational change.
    Pines J
    Nature; 1995 Jul; 376(6538):294-5. PubMed ID: 7630391
    [No Abstract]   [Full Text] [Related]  

  • 18. Substituted 2H-isoquinolin-1-ones as potent Rho-kinase inhibitors: part 3, aryl substituted pyrrolidines.
    Bosanac T; Hickey ER; Ginn J; Kashem M; Kerr S; Kugler S; Li X; Olague A; Schlyer S; Young ER
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3746-9. PubMed ID: 20471253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial ligand design targeted at protein families.
    Todorov NP; Buenemann CL; Alberts IL
    J Chem Inf Model; 2005; 45(2):314-20. PubMed ID: 15807493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of broad spectrum protein kinase inhibitors to probe the architecture of the malarial cyclin dependent protein kinase Pfmrk.
    Woodard CL; Keenan SM; Gerena L; Welsh WJ; Geyer JA; Waters NC
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4961-6. PubMed ID: 17588749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.